Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.

Margalit, Ofer, Harmsen, William S., Shacham-Shmueli, Einat, Voss, Molly M., Boursi, Ben, Wagner, Anna D., Cohen, Romain, Olswold, Curtis L., Saltz, Leonard B., Goldstein, Daniel A., Hurwitz, Herbert, Tebbutt, Niall C., Kabbinavar, Fairooz F., Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Chibaudel, Benoist, Grothey, Axel, Yoshino, Takayuki, Zalcberg, John, de Gramont, Aimery, Shi, Qian and Lenz, Heinz-Josef 2023. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database. European Journal of Cancer 178 , pp. 162-170. 10.1016/j.ejca.2022.10.022

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB)

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	0959-8049
Date of First Compliant Deposit:	17 April 2023
Date of Acceptance:	23 October 2022
Last Modified:	02 May 2023 22:45
URI:	https://orca.cardiff.ac.uk/id/eprint/158892

Actions (repository staff only)

Edit Item